Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3921258, 9 pages
https://doi.org/10.1155/2017/3921258
Research Article

Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma

1Department of Otorhinolaryngology, Umberto I University General Hospital, Università Politecnica delle Marche, Via Conca 71, 60126 Ancona, Italy
2Department of Otorhinolaryngology, Audiology and Phoniatrics “G. Ferreri”, University La Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy
3Department of Molecular and Clinical Sciences, Università Politecnica delle Marche, Via Tronto 10/a, 60126 Ancona, Italy
4Pathologic Anatomy and Histopathology Division, Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Via Conca 71, 60126 Ancona, Italy
5Department of Biomedical Sciences and Public Health, Section of Medical Statistics, Faculty of Medicine, Università Politecnica delle Marche, Via Tronto 10/a, 60126 Ancona, Italy
6Center of Clinical Pathology and Innovative Therapy, INRCA-IRCCS Italian National Institute, Via della Montagnola 81, 60127 Ancona, Italy

Correspondence should be addressed to Arisa Bajraktari; ti.oohay@38iratkarjab

Received 26 February 2017; Accepted 1 August 2017; Published 31 August 2017

Academic Editor: Vickram Ramkumar

Copyright © 2017 Massimo Re et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Chu and Y. J. Kim, “Laryngeal cancer: diagnosis and preoperative work-up,” Otolaryngologic Clinics of North America, vol. 41, no. 4, pp. 673–695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Y. Fan, “Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications,” Current Oncology Reports, vol. 6, no. 2, pp. 152–161, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. J. Marsit, B. C. Christensen, E. A. Houseman et al., “Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma,” Carcinogenesis, vol. 30, no. 3, pp. 416–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Worsham, K. M. Chen, V. Meduri et al., “Epigenetic events of disease progression in head and neck squamous cell carcinoma,” Archives of Otolaryngology—Head and Neck Surgery, vol. 132, no. 6, pp. 668–677, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Ambros, “The functions of animal microRNAs,” Nature, vol. 431, no. 7006, pp. 350–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. D. Zamore and B. Haley, “Ribo-gnome: the big world of small RNAs,” Science, vol. 309, no. 5740, pp. 1519–1524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Schickel, B. Boyerinas, S.-M. Park, and M. E. Peter, “MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death,” Oncogene, vol. 27, no. 45, pp. 5959–5974, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. V. Iorio, M. Ferracin, C.-G. Liu et al., “MicroRNA gene expression deregulation in human breast cancer,” Cancer Research, vol. 65, no. 16, pp. 7065–7070, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. A. Calin, M. Ferracin, A. Cimmino et al., “A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia,” The New England Journal of Medicine, vol. 353, no. 17, pp. 1793–1801, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. L. X. Yan, X. F. Huang, Q. Shao et al., “MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis,” RNA, vol. 14, no. 11, pp. 2348–2360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. Schetter, S. Y. Leung, J. J. Sohn et al., “MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma,” Journal of the American Medical Association, vol. 299, no. 4, pp. 425–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Chen and R. L. Stallings, “Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis,” Cancer Research, vol. 67, no. 3, pp. 976–983, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Avissar, B. C. Christensen, K. T. Kelsey, and C. J. Marsit, “MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma,” Clinical Cancer Research, vol. 15, no. 8, pp. 2850–2855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. S. Chang, W. J. Wei, I. Smith et al., “MicroRNA alterations in head and neck squamous cell carcinoma,” International Journal of Cancer, vol. 123, no. 12, pp. 2791–2797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Childs, M. Fazzari, G. Kung et al., “Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma,” The American Journal of Pathology, vol. 174, no. 3, pp. 736–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Ramdas, U. Giri, C. L. Ashorn et al., “miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue,” Head & Neck, vol. 31, no. 5, pp. 642–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Re, A. Çeka, C. Rubini et al., “MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma,” Laryngoscope, vol. 125, no. 9, pp. E306–E312, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. X.-B. Long, G.-B. Sun, S. Hu et al., “Let-7a microrna functions as a potential tumor suppressor in human laryngeal cancer,” Oncology Reports, vol. 22, no. 5, pp. 1189–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. M. Cai, X. L. Bao, X. H. Kong, W. Jinag, M. R. Mao, J. S. Chu et al., “Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met,” International Journal of Molecular Medicine, vol. 25, no. 4, pp. 565–571, 2010. View at Publisher · View at Google Scholar
  20. J. Liu, D. P. Lei, T. Jin, X. N. Zhao, G. Li, and X. L. Pan, “Altered Expression of miR-21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas,” Asian Pacific Journal of Cancer Prevention, vol. 12, pp. 2653–2657, 2011. View at Google Scholar
  21. R. Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2013, http://www.R-project.org/.
  22. G. J. Gordon, R. V. Jensen, L. Hsiao et al., “Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma,” Cancer Research, vol. 62, no. 17, pp. 4963–4967, 2002. View at Google Scholar · View at Scopus
  23. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. W. P. Kloosterman and R. H. A. Plasterk, “The diverse functions of microRNAs in animal development and disease,” Developmental Cell, vol. 11, no. 4, pp. 441–450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Gunawardena, J. Fitzgerald, A. Morley, D. J. Hussey, C. M. Woods, and A. S. Carney, “Micro-ribonucleic acids in head and neck cancer: an introduction,” The Journal of Laryngology & Otology, vol. 127, no. S2, pp. S2–S7, 2013. View at Publisher · View at Google Scholar
  26. H. F. Tu, S. C. Lin, and K. W. Chang, “MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance,” Current Opinion in Otolaryngology and Head and Neck Surgery, vol. 21, no. 2, pp. 104–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Calin, C. Sevignani, C. D. Dumitru et al., “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999–3004, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Slaby, M. Svoboda, and P. Fabian, “Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer,” Oncology, vol. 72, no. 5-6, pp. 397–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Yanaihara, N. Caplen, E. Bowman et al., “Unique microRNA molecular profiles in lung cancer diagnosis and prognosis,” Cancer Cell, vol. 9, no. 3, pp. 189–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. S.-L. Yu, H.-Y. Chen, G.-C. Chang et al., “MicroRNA signature predicts survival and relapse in lung cancer,” Cancer Cell, vol. 13, no. 1, pp. 48–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Tian, M. Li, J. Ge et al., “MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours,” Tumor Biology, vol. 35, no. 6, pp. 5953–5963, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Y. Wu, T. H. Zhang, L. M. Qu, J. P. Feng, L. L. Tian, B. H. Zhang et al., “MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression,” International Journal of Clinical and. Experimental Pathology, vol. 7, pp. 56–63, 2013. View at Google Scholar
  33. X. Li, H. Wang, X. Peng, H. Zhou, and X. Wang, “MiR-1297 mediates PTEN expression and contributes to cell progression in LSCC,” Biochemical and Biophysical Research Communications, vol. 427, no. 2, pp. 254–260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Cao, L. Zhou, J. Zhang et al., “Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma,” Head and Neck, vol. 35, no. 5, pp. 720–728, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Re, A. Zizzi, L. Ferrante et al., “p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival,” European Archives of Oto-Rhino-Laryngology, vol. 271, no. 6, pp. 1641–1651, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Cao, R. Fan, L. Wang et al., “Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells,” Tumor Biology, vol. 34, no. 2, pp. 963–971, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Kumar, A. Yadav, J. Lang, T. N. Teknos, and P. Kumar, “Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis,” PLoS ONE, vol. 7, no. 5, Article ID e37601, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Takamizawa, H. Konishi, K. Yanagisawa et al., “Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival,” Cancer Research, vol. 64, no. 11, pp. 3753–3756, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Akao, Y. Nakagawa, and T. Naoe, “let-7 microRNA functions as a potential growth suppressor in human colon cancer cells,” Biological & Pharmaceutical Bulletin, vol. 29, no. 5, pp. 903–906, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. D. Sekuklu, M. T. A. Donoghue, and C. Spillane, “miR-21 as a key regulator of oncogenic processes,” Biochemical Society Transactions, vol. 37, no. 4, pp. 918–925, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. M. L. Si, S. Zhu, H. Wu, Z. Lu, F. Wu, and Y.-Y. Mo, “miR-21-mediated tumor growth,” Oncogene, vol. 26, no. 19, pp. 2799–2803, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. A. Chan, A. M. Krichevsky, and K. S. Kosik, “MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells,” Cancer Research, vol. 65, no. 14, pp. 6029–6033, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Roldo, E. Missiaglia, J. P. Hagan et al., “MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior,” Journal of Clinical Oncology, vol. 24, no. 29, pp. 4677–4684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Kimura, S. Naganuma, D. Susuki et al., “Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: MiR-205 and miR-21 are specific markers for HNSCC and ESCC,” Oncology Reports, vol. 23, no. 6, pp. 1625–1633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Zhu, H. Wu, F. Wu, D. Nie, S. Sheng, and Y.-Y. Mo, “MicroRNA-21 targets tumor suppressor genes in invasion and metastasis,” Cell Research, vol. 18, no. 3, pp. 350–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Ren, D. Zhu, M. Liu, Y. Sun, and L. Tian, “Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma,” European Journal of Cancer, vol. 46, no. 18, pp. 3409–3416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Liu, H. Wu, T. Liu et al., “Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma,” Cell Research, vol. 19, no. 7, pp. 828–837, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Assimakopoulos, E. Kolettas, N. Zagorianakou, A. Evangelou, A. Skevas, and N. J. Agnantis, “Prognostic significance of p53 in the cancer of the larynx,” Anticancer Research, vol. 20, no. 5, pp. 3555–3564, 2000. View at Google Scholar · View at Scopus
  49. F. M. Gioacchini, M. Alicandri-Ciufelli, C. Rubini, G. Magliulo, and M. Re, “Prognostic value of Bcl-2 expression in squamous cell carcinoma of the larynx: a systematic review,” International Journal of Biological Markers, vol. 30, no. 2, pp. e155–e160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. F. M. Gioacchini, M. Alicandri-Ciufelli, G. Magliulo, C. Rubini, L. Presutti, and M. Re, “The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma,” European Archives of Oto-Rhino-Laryngology, vol. 272, no. 7, article 3117, pp. 1569–1576, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Mittari, A. Charalabopoulos, A. Batistatou, and K. Charalabopoulos, “The role of E-cadherin/catenin complex in laryngeal cancer,” Experimental Oncology, vol. 27, no. 4, pp. 257–261, 2005. View at Google Scholar · View at Scopus
  52. C. Chen, “MicroRNAs as oncogenes and tumor suppressors,” The New England Journal of Medicine, vol. 353, no. 17, pp. 1768–1771, 2005. View at Publisher · View at Google Scholar · View at Scopus